New pill aims to tame seizures in rare brain disorders
Disease control
Not yet recruiting
This early-stage trial tests an oral drug called SVG103 (paxalisib) in 15 adults with rare brain conditions (FCD-II, TSC, or HME) that cause hard-to-control seizures. The main goal is to see if the drug is safe and tolerable, with a secondary look at whether it reduces seizure fr…
Phase: PHASE1, PHASE2 • Sponsor: Sovargen • Aim: Disease control
Last updated May 08, 2026 12:01 UTC